These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38718848)

  • 21. MeCP2 inactivation of LncRNA GAS5 triggers cardiac fibroblasts activation in cardiac fibrosis.
    Tao H; Shi P; Zhao XD; Xuan HY; Ding XS
    Cell Signal; 2020 Oct; 74():109705. PubMed ID: 32634579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of TRPC6 channels ameliorates renal fibrosis and contributes to renal protection by soluble klotho.
    Wu YL; Xie J; An SW; Oliver N; Barrezueta NX; Lin MH; Birnbaumer L; Huang CL
    Kidney Int; 2017 Apr; 91(4):830-841. PubMed ID: 27979597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LncRNA Gas5 regulates Fn1 deposition via Creb5 in renal fibrosis.
    Su H; Xie J; Wen L; Wang S; Chen S; Li J; Qi C; Zhang Q; He X; Zheng L; Wang L
    Epigenomics; 2021 May; 13(9):699-713. PubMed ID: 33876672
    [No Abstract]   [Full Text] [Related]  

  • 24. LncRNA GAS5 controls cardiac fibroblast activation and fibrosis by targeting miR-21 via PTEN/MMP-2 signaling pathway.
    Tao H; Zhang JG; Qin RH; Dai C; Shi P; Yang JJ; Deng ZY; Shi KH
    Toxicology; 2017 Jul; 386():11-18. PubMed ID: 28526319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. lncRNA GAS5 restrains CCl
    Dong Z; Li S; Wang X; Si L; Ma R; Bao L; Bo A
    Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G539-G550. PubMed ID: 30735452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LncRNA HOTAIR promotes renal interstitial fibrosis by regulating Notch1 pathway via the modulation of miR-124.
    Zhou H; Gao L; Yu ZH; Hong SJ; Zhang ZW; Qiu ZZ
    Nephrology (Carlton); 2019 Apr; 24(4):472-480. PubMed ID: 29717517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcriptomic analysis of the mechanisms of alleviating renal interstitial fibrosis using the traditional Chinese medicine Kangxianling in a rat model.
    Jiang Y; Zhu Y; Zhen T; Li J; Xing K; He L; Zhu S
    Sci Rep; 2020 Jun; 10(1):10682. PubMed ID: 32606425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal Fibrosis, Immune Cell Infiltration and Changes of TRPC Channel Expression after Unilateral Ureteral Obstruction in Trpc6-/- Mice.
    Kong W; Haschler TN; Nürnberg B; Krämer S; Gollasch M; Markó L
    Cell Physiol Biochem; 2019; 52(6):1484-1502. PubMed ID: 31099508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blocking interleukin-6 trans-signaling protects against renal fibrosis by suppressing STAT3 activation.
    Chen W; Yuan H; Cao W; Wang T; Chen W; Yu H; Fu Y; Jiang B; Zhou H; Guo H; Zhao X
    Theranostics; 2019; 9(14):3980-3991. PubMed ID: 31281526
    [No Abstract]   [Full Text] [Related]  

  • 30. Long non‑coding RNA GAS5 regulates myocardial ischemia‑reperfusion injury through the PI3K/AKT apoptosis pathway by sponging miR‑532‑5p.
    Han Y; Wu N; Xia F; Liu S; Jia D
    Int J Mol Med; 2020 Mar; 45(3):858-872. PubMed ID: 31985016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LncRNA GAS5 inhibits miR-579-3p to activate SIRT1/PGC-1α/Nrf2 signaling pathway to reduce cell pyroptosis in sepsis-associated renal injury.
    Ling H; Li Q; Duan ZP; Wang YJ; Hu BQ; Dai XG
    Am J Physiol Cell Physiol; 2021 Jul; 321(1):C117-C133. PubMed ID: 34010066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long non-coding RNA FABP5P3/miR-22 axis improves TGFβ1-induced fatty acid oxidation deregulation and fibrotic changes in proximal tubular epithelial cells of renal fibrosis.
    Wang J; Zeng J; Yin G; Deng Z; Wang L; Liu J; Yao K; Long Z; Jiang X; Tan J
    Cell Cycle; 2023 Feb; 22(4):433-449. PubMed ID: 36196456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long noncoding RNA GAS5 inhibits cell proliferation and fibrosis in diabetic nephropathy by sponging miR-221 and modulating SIRT1 expression.
    Ge X; Xu B; Xu W; Xia L; Xu Z; Shen L; Peng W; Huang S
    Aging (Albany NY); 2019 Oct; 11(20):8745-8759. PubMed ID: 31631065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of YTHDF1 in renal fibrosis progression via up-regulating YAP.
    Xing J; He YC; Wang KY; Wan PZ; Zhai XY
    FASEB J; 2022 Feb; 36(2):e22144. PubMed ID: 34990050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the m
    Ni W; Yao S; Zhou Y; Liu Y; Huang P; Zhou A; Liu J; Che L; Li J
    Mol Cancer; 2019 Oct; 18(1):143. PubMed ID: 31619268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Knockdown of lncRNA MALAT1 attenuates renal interstitial fibrosis through miR-124-3p/ITGB1 axis.
    Xia W; Chen X; Zhu Z; Chen H; Li B; Wang K; Huang L; Liu Z; Chen Z
    Sci Rep; 2023 Oct; 13(1):18076. PubMed ID: 37872392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NLRP3 Deficiency Attenuates Renal Fibrosis and Ameliorates Mitochondrial Dysfunction in a Mouse Unilateral Ureteral Obstruction Model of Chronic Kidney Disease.
    Guo H; Bi X; Zhou P; Zhu S; Ding W
    Mediators Inflamm; 2017; 2017():8316560. PubMed ID: 28348462
    [No Abstract]   [Full Text] [Related]  

  • 38. Secreted Frizzled-related protein 1 (Sfrp1) regulates the progression of renal fibrosis in a mouse model of obstructive nephropathy.
    Matsuyama M; Nomori A; Nakakuni K; Shimono A; Fukushima M
    J Biol Chem; 2014 Nov; 289(45):31526-33. PubMed ID: 25253698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Type 1 angiotensin receptors on macrophages ameliorate IL-1 receptor-mediated kidney fibrosis.
    Zhang JD; Patel MB; Griffiths R; Dolber PC; Ruiz P; Sparks MA; Stegbauer J; Jin H; Gomez JA; Buckley AF; Lefler WS; Chen D; Crowley SD
    J Clin Invest; 2014 May; 124(5):2198-203. PubMed ID: 24743144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toll-like receptor signaling and SIGIRR in renal fibrosis upon unilateral ureteral obstruction.
    Skuginna V; Lech M; Allam R; Ryu M; Clauss S; Susanti HE; Römmele C; Garlanda C; Mantovani A; Anders HJ
    PLoS One; 2011 Apr; 6(4):e19204. PubMed ID: 21544241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.